The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

Background: The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial aimed to determine whether or not oral Δ9-tetrahydrocannabinol (Δ9-THC) slowed the course of progressive multiple sclerosis (MS); evaluate safety of cannabinoid administration; and, improve methods for testing tr...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Susan Ball, Jane Vickery, Jeremy Hobart, Dave Wright, Colin Green, James Shearer, Andrew Nunn, Mayam Gomez Cano, David MacManus, David Miller, Shahrukh Mallik, John Zajicek
Формат: Artigo
Язык:Inglês
Опубликовано: NIHR Journals Library 2015-02-01
Серии:Health Technology Assessment
Предметы:
multiple sclerosis
cannabinoids
dronabinol
magnetic resonance imaging
randomised controlled trial
cupid trial
Online-ссылка:https://doi.org/10.3310/hta19120
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы